» Articles » PMID: 10995444

Assembly of the Dystrophin-associated Protein Complex Does Not Require the Dystrophin COOH-terminal Domain

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2000 Sep 20
PMID 10995444
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Dystrophin is a multidomain protein that links the actin cytoskeleton to laminin in the extracellular matrix through the dystrophin associated protein (DAP) complex. The COOH-terminal domain of dystrophin binds to two components of the DAP complex, syntrophin and dystrobrevin. To understand the role of syntrophin and dystrobrevin, we previously generated a series of transgenic mouse lines expressing dystrophins with deletions throughout the COOH-terminal domain. Each of these mice had normal muscle function and displayed normal localization of syntrophin and dystrobrevin. Since syntrophin and dystrobrevin bind to each other as well as to dystrophin, we have now generated a transgenic mouse deleted for the entire dystrophin COOH-terminal domain. Unexpectedly, this truncated dystrophin supported normal muscle function and assembly of the DAP complex. These results demonstrate that syntrophin and dystrobrevin functionally associate with the DAP complex in the absence of a direct link to dystrophin. We also observed that the DAP complexes in these different transgenic mouse strains were not identical. Instead, the DAP complexes contained varying ratios of syntrophin and dystrobrevin isoforms. These results suggest that alternative splicing of the dystrophin gene, which naturally generates COOH-terminal deletions in dystrophin, may function to regulate the isoform composition of the DAP complex.

Citing Articles

Native DGC structure rationalizes muscular dystrophy-causing mutations.

Liu S, Su T, Xia X, Zhou Z Nature. 2024; 637(8048):1261-1271.

PMID: 39663457 DOI: 10.1038/s41586-024-08324-w.


Biophysical characterization of the dystrophin C-terminal domain: Dystrophin interacts differentially with dystrobrevin isoforms.

Upadhyay V, Ray S, Panja S, Saviola A, Maluf N, Mallela K J Biol Chem. 2024; 300(12):108002.

PMID: 39551137 PMC: 11719305. DOI: 10.1016/j.jbc.2024.108002.


Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy.

Kiperman T, Ma K Int J Mol Sci. 2024; 25(9).

PMID: 38731986 PMC: 11083552. DOI: 10.3390/ijms25094767.


Nonsense-mediated mRNA decay, a simplified view of a complex mechanism.

Carrard J, Lejeune F BMB Rep. 2023; 56(12):625-632.

PMID: 38052423 PMC: 10761751.


Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.

Szwec S, Kaplucha Z, Chamberlain J, Konieczny P BioDrugs. 2023; 38(1):95-119.

PMID: 37917377 PMC: 10789850. DOI: 10.1007/s40259-023-00632-3.


References
1.
Bonnemann C, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E . Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 1995; 11(3):266-73. DOI: 10.1038/ng1195-266. View

2.
Noguchi S, MCNALLY E, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M . Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science. 1995; 270(5237):819-22. DOI: 10.1126/science.270.5237.819. View

3.
Jung D, Yang B, Meyer J, Chamberlain J, Campbell K . Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem. 1995; 270(45):27305-10. DOI: 10.1074/jbc.270.45.27305. View

4.
Dwyer T, Froehner S . Direct binding of Torpedo syntrophin to dystrophin and the 87 kDa dystrophin homologue. FEBS Lett. 1995; 375(1-2):91-4. DOI: 10.1016/0014-5793(95)01176-f. View

5.
Ahn A, Freener C, Gussoni E, Yoshida M, Ozawa E, Kunkel L . The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem. 1996; 271(5):2724-30. DOI: 10.1074/jbc.271.5.2724. View